UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

 

FORM 25

 

 

NOTIFICATION OF REMOVAL FROM LISTING

AND/OR REGISTRATION UNDER SECTION 12(b)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-38624

 

 

Vaccinex, Inc.

The Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

 

 

1895 Mount Hope Avenue

Rochester, New York 14620

(585) 271-2700

(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)

Common Stock, par value $0.0001 per share

(Description of class of securities)

 

 

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

 

  ☐

17 CFR 240.12d2-2(a)(1)

 

  ☐

17 CFR 240.12d2-2(a)(2)

 

  ☐

17 CFR 240.12d2-2(a)(3)

 

  ☐

17 CFR 240.12d2-2(a)(4)

 

  ☐

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.

 

  ☒

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements of the Securities Exchange Act of 1934, Vaccinex, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

 

March 17, 2025

     By  

/s/ Maurice Zauderer

     

Chief Executive Officer

Date       Name      Title

 

 

 

Grafico Azioni Vaccinex (NASDAQ:VCNX)
Storico
Da Mar 2025 a Apr 2025 Clicca qui per i Grafici di Vaccinex
Grafico Azioni Vaccinex (NASDAQ:VCNX)
Storico
Da Apr 2024 a Apr 2025 Clicca qui per i Grafici di Vaccinex